FIELD: medicine, immunology. SUBSTANCE: invention relates to modulation of expression of cytokines Th1/Th2 by ribavirin and its analogs in activated T-lymphocytes. Invention involves expression of lymphokines Th1/Th2 in T-cells of patient (human) by ribavirin adding to cells in doses that stimulate expression of one of lymphokines tumor necrosis factor-α, interleukin-2 and interferon-γ but inhibit expression of lymphokine Th2 interleukin-4. The advantage of invention involves the development of a method of modulation of lymphokine, i. e. enhancement of response of Th1 in simultaneous reversion of Th2 phenotype and vice versus. EFFECT: improved method of expression modulation. 8 cl, 7 dwg, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| MODULATION OF IMMUNE RESPONSE DUE TO RIBAVIRIN | 1999 |
|
RU2211698C2 |
| PURINE L-NUCLEOSIDES, THEIR ANALOGUES AND USING | 1997 |
|
RU2183639C2 |
| MONOCYCLIC L-NUCLEOSIDES, THEIR ANALOGUES AND USING | 1997 |
|
RU2188828C2 |
| METHOD TO DIAGNOSE ALLERGIC REACTIONS | 2009 |
|
RU2536291C2 |
| TREATMENT | 2009 |
|
RU2554801C2 |
| RECOMBINANT CHIMERIC PROTEIN ANTH1, NUCLEIC ACID ENCODING ITS AND THEIR USING | 2003 |
|
RU2322455C2 |
| NUCLEIC ACIDS MODIFIED WITH AMINO ACIDS | 1995 |
|
RU2154638C2 |
| METHOD FOR DIAGNOSING, TREATING AND PREDICTING SOLID NONLYMPHOID TUMORS AND THEIR METASTASES | 1994 |
|
RU2144675C1 |
| METHOD OF ENHANCEMENT OF IMMUNE RESPONSE TO ANTIGENE IN MAMMALS | 2004 |
|
RU2341289C2 |
| RAPID ASSAYS FOR T-CELL ACTIVATION BY RNA MEASUREMENTS USING FLOW CYTOMETRY | 2013 |
|
RU2671707C2 |
